Nejat Egilmez, PhD

University of Louisville
Louisville, KY
USA Papers:
PS.2 Targeting the Host to Reverse Infection-induced Immune Suppression Affords a Novel Approach to Therapy and Vaccine Development against Neisseria gonorrhoeae